Milan, Italy

Maria Ines Colnaghi


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1993-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Maria Ines Colnaghi: Innovator in Monoclonal Antibody Development

Introduction

Maria Ines Colnaghi is an accomplished inventor based in Milan, Italy, recognized for her significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With two patents to her name, her work has implications for the treatment of various health conditions associated with anthracycline antibiotics.

Latest Patents

Colnaghi's latest patents focus on monoclonal antibodies that serve as antidotes for anthracycline antibiotics. The first patent pertains to the development of anti-anthracycline antibiotic monoclonal antibodies that are effective as antidotes for anthracycline antibiotics and for treating anthracycline extravasation lesions and alopecia. The second patent describes a monoclonal antibody that recognizes a specific epitope of anthracycline glycosides, including Doxorubicin. This antibody is unique in its ability to selectively identify epitopes located near the aromatic D ring of the anthracycline molecule, showcasing innovative advancements in targeted therapeutics.

Career Highlights

Maria Ines Colnaghi is currently affiliated with the Istituto Nazionale per Lo Studio e La Cura dei Tumori. Throughout her career, she has dedicated herself to research that enhances cancer treatment options, specifically utilizing innovative monoclonal antibody technologies to address challenges faced by patients undergoing anthracycline chemotherapy.

Collaborations

Colnaghi collaborates with esteemed colleagues, including Andrea Balsari and Mario Ghione, fostering a research environment that emphasizes teamwork and innovation. Together, they explore new frontiers in antibody-based therapies, contributing to the evolving landscape of cancer treatment.

Conclusion

With a strong focus on developing monoclonal antibodies for critical medical applications, Maria Ines Colnaghi exemplifies the role of innovative inventors in advancing healthcare solutions. Her patents provide promising avenues for enhancing patient care in oncology, reflecting her commitment to making a significant impact in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…